Tyloxapol: Difference between revisions
Content deleted Content added
added chembl id |
Updating {{drugbox}} (changes to verified fields - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report [[Wikip |
||
| Line 1: | Line 1: | ||
{{Unreferenced stub|auto=yes|date=December 2009}} |
{{Unreferenced stub|auto=yes|date=December 2009}} |
||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
| verifiedrevid = 376126506 |
| verifiedrevid = 376126506 |
||
| IUPAC_name = |
| IUPAC_name = |
||
| Line 10: | Line 11: | ||
| PubChem = 71388 |
| PubChem = 71388 |
||
| DrugBank = |
| DrugBank = |
||
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|||
| ChEMBL = 1201548 |
| ChEMBL = 1201548 |
||
| chemical_formula = (C<sub>15</sub>H<sub>21</sub>O(C<sub>2</sub>H<sub>4</sub>O)<sub>m</sub>)<sub>n</sub> |
| chemical_formula = (C<sub>15</sub>H<sub>21</sub>O(C<sub>2</sub>H<sub>4</sub>O)<sub>m</sub>)<sub>n</sub> |
||
Revision as of 07:39, 23 May 2011
 |
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.209.660 |
| Chemical and physical data | |
| Formula | (C15H21O(C2H4O)m)n |
| Molar mass | variable |
  (what is this?) (verify) | |
Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type. It is used as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions, administered by inhalation through a nebulizer or with a stream of oxygen. With intraperitoneal injection, tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins.
 | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |